Sarepta Therapeutics: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 10:06 AM ET
Last Updated - Aug 08, 2024, 10:06 AM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported second-quarter profit of $6.5 million.
The Cambridge, Massachusetts-based company said it had net income of 7 cents per share.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.
The biopharmaceutical company posted revenue of $362.9 million in the period, falling short of Street forecasts. Seven analysts surveyed by Zacks expected $386.9 million.
